Reporter Aug 12 2022

Nanoparticles boost anti-cancer immunity

An ingenious targeted nanoparticle approach developed by Vanderbilt researchers reduced tumor burden in a model of ovarian cancer.

Mitochondria and retinal degeneration

Vanderbilt researchers have developed a new cellular model for exploring mitochondrial dysfunction in age-related macular degeneration, the leading cause of blindness in people over 65.

Jeff Balser, MD, PhD, discussed results of VUMC’s Culture Survey during the Leadership Assembly.

Supporting ‘Team VUMC’: Leadership Assembly Highlights

Growth across both Vanderbilt University Medical Center and the communities it serves spotlights the need to bolster collaboration and communication to efficiently provide care to patients and ensure well-being of the workforce, Medical Center leaders said during streaming of the August 2022 Leadership Assembly.

Genotype-specific blood counts

Vanderbilt researchers report genotype-specific reference ranges to improve interpretation of laboratory blood results in African Americans with a common gene variant that lowers white blood cell counts.

Cell-free breast cancer “biopsy”

The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer.

Luke and Susan Simons recently made a gift to establish the Susan and Luke Simons Directorship at Vanderbilt-Ingram Cancer Center.

Couple’s gift helps support immunotherapy research

Luke and Susan Simons have endowed a new directorship that will support research so that more people can benefit from immunotherapies.

1 2